Cargando…

Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study

OBJECTIVE: Type 2 diabetes is an established risk factor for development of hepatic steatosis and nonalcoholic fatty liver disease (NAFLD). We aimed to determine the prevalence and clinical correlates of these conditions in a large cohort of people with type 2 diabetes. RESEARCH DESIGN AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williamson, Rachel M., Price, Jackie F., Glancy, Stephen, Perry, Elisa, Nee, Lisa D., Hayes, Peter C., Frier, Brian M., Van Look, Liesbeth A.F., Johnston, Geoffrey I., Reynolds, Rebecca M., Strachan, Mark W.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114489/ https://www.ncbi.nlm.nih.gov/pubmed/21478462 http://dx.doi.org/10.2337/dc10-2229

Ejemplares similares

Association Between Excessive Daytime Sleepiness and Severe Hypoglycemia in People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study
por: Inkster, Berit, et al.
Publicado: (2013)

The Edinburgh Type 2 Diabetes Study: study protocol
por: Price, Jackie F, et al.
Publicado: (2008)

Diabetic Retinopathy and Cognitive Decline in Older People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study
por: Ding, Jie, et al.
Publicado: (2010)

Addition of hyaluronic acid to the FIB‐4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes Study
por: Grecian, Sheila M., et al.
Publicado: (2021)

Morning Cortisol Levels and Cognitive Abilities in People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study
por: Reynolds, Rebecca M., et al.
Publicado: (2010)

Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study
por: Morling, J.R., et al.
Publicado: (2016)

γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study
por: Morling, Joanne R., et al.
Publicado: (2015)

Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study
por: Feinkohl, Insa, et al.
Publicado: (2013)

Association Between Raised Inflammatory Markers and Cognitive Decline in Elderly People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study
por: Marioni, Riccardo E., et al.
Publicado: (2010)

Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study
por: Reynolds, Rebecca M, et al.
Publicado: (2012)

Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study
por: Price, Anna H., et al.
Publicado: (2017)

The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors
por: Feinkohl, Insa, et al.
Publicado: (2015)

Retinal venular tortuosity and fractal dimension predict incident retinopathy in adults with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
por: Forster, Rachel B., et al.
Publicado: (2021)

Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes Study
por: Sluiman, Anniek J., et al.
Publicado: (2021)

Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes
por: Feinkohl, Insa, et al.
Publicado: (2015)

Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
por: Han, Eugene, et al.
Publicado: (2021)

Association of N-Terminal Pro-Brain Natriuretic Peptide with Cognitive Function and Depression in Elderly People with Type 2 Diabetes
por: Feinkohl, Insa, et al.
Publicado: (2012)

Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
por: Kim, Mi-kyung
Publicado: (2021)

Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
por: Han, Eugene, et al.
Publicado: (2021)

Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes
por: Jenks, Sara J., et al.
Publicado: (2017)

Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications
por: Tripolino, Cesare, et al.
Publicado: (2019)

The Association between Pancreatic Steatosis and Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
por: Jeong, Jee Sun, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
por: Dharmalingam, Mala, et al.
Publicado: (2018)

Effects of Acute Insulin-Induced Hypoglycemia on Spatial Abilities in Adults With Type 1 Diabetes
por: Wright, Rohana J., et al.
Publicado: (2009)

Acute Hypoglycemia Impairs Executive Cognitive Function in Adults With and Without Type 1 Diabetes
por: Graveling, Alex J., et al.
Publicado: (2013)

Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes
por: Lazo, Mariana, et al.
Publicado: (2010)

Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes
por: Huang, Zhe, et al.
Publicado: (2022)

Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study
por: Cardoso, Claudia R. L., et al.
Publicado: (2021)

The Non-Resident Fellowships of the Royal College of Surgeons of Edinburgh
por: Strachan, John M.
Publicado: (1856)

Depression as a risk factor for dementia in older people with type 2 diabetes and the mediating effect of inflammation
por: Carr, Alistair L., et al.
Publicado: (2020)

Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
por: Ulasoglu, Celal, et al.
Publicado: (2021)

Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
por: Lomonaco, Romina, et al.
Publicado: (2016)

The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
por: Kosmalski, Marcin, et al.
Publicado: (2022)

Differential Intrahepatic Phospholipid Zonation in Simple Steatosis and Nonalcoholic Steatohepatitis
por: Wattacheril, Julia, et al.
Publicado: (2013)

Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
por: Ganbold, Munkhzul, et al.
Publicado: (2019)

Markers of Glucagon Resistance Improve With Reductions in Hepatic Steatosis and Body Weight in Type 2 Diabetes
por: Kjeldsen, Sasha A S, et al.
Publicado: (2023)

Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes
por: Ramírez, Elisa, et al.
Publicado: (2013)

Effects of Metformin on Hepatic Steatosis in Adults with Nonalcoholic Fatty Liver Disease and Diabetes: Insights from the Cellular to Patient Levels
por: Pinyopornpanish, Kanokwan, et al.
Publicado: (2021)

The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes
por: Wahren, John, et al.
Publicado: (2012)

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship
por: Muzica, Cristina M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v5oe5u12c8ee1egbo26c8gc37m